Back to the main directory
EarningsReview / Equity
- Back to the basics - WEFTEC 2025 takeaways by BNP Paribas
- From regional roots to a leading domestic franchise by BNP Paribas
- Closer to Margin Reset? Scenario Analysis Examines Bull and Bear Cases; We Stay (-) Ahead of 2Q Results by BNP Paribas
- Corporate Contact: Key Takeaways Ahead of 3Q25 Results by BNP Paribas
- Sept. U.S. SAAR: Even Excluding 3Q’s “EV Pre-Buy” - Demand Proves Strong by BNP Paribas
- 1H26 pre-close statement: Lower end of expectation, but somewhat expected by BNP Paribas
- Tesco 1H26 - EBIT solidly ahead, guidance raised by BNP Paribas
- INVEST SECURITIES - HOPSCOTCH : Disappointing H1 results ; still solid fundamentals - BUY, TP 21,8€ vs 27,3€ by Invest Securities
- INVEST SECURITIES - AFFLUENT MEDICAL : Marge financière étroite, jalons capitaux en 2026 - ACHAT, OC 2,5€ vs 2,7€ by Invest Securities
- Postcard from Antwerp by BNP Paribas
- Corporate contact by BNP Paribas
- LITHIUM, STEEL ACTION PLAN, US AUTO by BNP Paribas
- Non material data changes by BNP Paribas
- First thoughts: very strong guidance uplift by BNP Paribas
- EDA is the NVDA of software by BNP Paribas
- An AI software play by BNP Paribas
- Tesco 1H26: off the call by BNP Paribas
- Corporate contact: Key takeaways by BNP Paribas
- FDA clearance and CE marking for Fusion GI by BNP Paribas
- Outokumpu - Time to turn positive as EU ‘plans tariff hike to 50%’ by Danske Bank Equity Research
- CMD feedback and Q3’25 preview by BNP Paribas
- Harvesting seeds sown long ago (and planting some new ones); & questions for mgmt by BNP Paribas
- H126 trading update and 15 questions for management by BNP Paribas
- TIM Enterprise Analyst Meeting - Feedback by BNP Paribas
- Climate Risks - Owning Up by BNP Paribas